Moving From Heart Failure Guidelines to Clinical Practice: Gaps Contributing to Readmissions in Patients With

Pupalan Iyngkaran1, Danny Liew2, Christopher Neil3

  • 1Northern Territory Medical Program, Flinders University, Darwin, NT, Australia.

Insights

Guidelines for congestive heart failure (CHF) readmissions often overlook patients with multiple comorbidities and the elderly. This review highlights gaps in care for these complex populations across CHF phases.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Public Health

Background:

  • Congestive heart failure (CHF) management involves a complex journey through acute, chronic, and palliative phases.
  • Multidisciplinary care is essential, spanning hospital and community settings.
  • Existing guidelines may not adequately address the needs of patients with multiple comorbidities and the elderly.

Purpose of the Study:

  • To identify and discuss critical gaps in current congestive heart failure (CHF) guidelines.
  • To examine the unique challenges faced by elderly patients and those with multiple comorbidities in CHF management.
  • To explore the 3-phase journey of CHF patients and the associated care requirements.

Main Methods:

  • Literature review focusing on congestive heart failure (CHF) readmissions, comorbidities, and geriatric care.
  • Analysis of current guideline deficiencies in managing complex CHF patient populations.
  • Exploration of the interplay between comorbidities, aging, and CHF outcomes.

Main Results:

  • Significant gaps exist in guidelines for managing elderly CHF patients and those with multiple comorbidities.
  • Comorbidities such as diabetes, COPD, renal impairment, and hypertension complicate CHF care.
  • Geriatric syndromes like frailty and confusion present additional management challenges.

Conclusions:

  • Current CHF management systems often fail to comprehensively address the needs of elderly patients and those with multiple comorbidities.
  • Improved guidelines and integrated care models are necessary to optimize outcomes for these vulnerable populations.
  • Addressing guideline gaps is crucial for reducing CHF readmissions and improving quality of life.

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
577
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
907
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.6K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
877
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
332
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
963